Skip to NavigationSkip to content

GSK rebrands AIDS drugs to foil illegal imports

Published on 02/03/05 at 04:06pm

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.

The company said parallel importers were costing it hundreds of millions of pounds and undermining relief efforts in a region home to two thirds of the world's AIDS sufferers.

GSK supplies large volumes of its antiretroviral drugs Combivir and Epivir to AIDS sufferers in the developing world via its not-for-profit programmes and the company says new design and colour changes will make it difficult for parallel importers to resell the drugs in the developed world.

The drugs will have the same chemical makeup as the white tablets sold in Europe but will be red-coated and arrive in unique packaging with easily traceable codes.


Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches